单克隆抗体（MABS）市场[按产品类型（全人，小鼠，嵌合）;通过生产系统（哺乳动物细胞培养，微生物发酵）;通过指示（癌症，炎症，心血管疾病，移植抑制，呼吸和传染病）;通过技术平台（转基因小鼠，抗体药物缀合物，噬菌体展示）;通过护理递送设定通过护理递送设定的目标作用机制（CGRP，HER2，CTLA4，TNFα，EGFR，VEGF，抗CD，抗IL，IgG，PD-1 / PD-L1）;通过药物类型和划分]：市场规模和预测，2017年 - 2026年

Table of Contents

1. Overview and Scope
   1. Research goal & scope
   2. Research assumptions
   3. Research methodology
      1. Primary data sources
      2. Secondary data sources
   4. Key take-away
   5. Stakeholders
2. Executive Summary
   1. Market definition
   2. Market segmentation
3. Monoclonal Antibodies Market Insights
   1. Monoclonal Antibodies – Industry snapshot
   2. Monoclonal Antibodies - Ecosystem analysis
   3. Monoclonal Antibodies Market Dynamics
      1. Monoclonal Antibodies – Market Forces
         1. Monoclonal Antibodies Market Driver Analysis
         2. Monoclonal Antibodies Market Restraint/Challenges analysis
         3. Monoclonal Antibodies Market Opportunity Analysis
      2. Industry analysis - Porter's five forces
         1. Bargaining power of supplier
         2. Bargaining power of buyer
         3. Threat of substitute
         4. 新参赛者的威胁
         5. 比赛学位
      3. Monoclonal Antibodies Market PEST Analysis, 2017
      4. Monoclonal Antibodies Market Value Chain Analysis
      5. Monoclonal Antibodies Industry Trends
      6. Competitive Ranking Analysis
4. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Product Type
   1. Key Findings
   2. Fully Human
   3. 小鼠
   4. Chimeric
   5. Humanized
5. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Production System
   1. Key Findings
   2. Mammalian Cell Culture
   3. Microbial Fermentation
6. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Indication
   1. Key Findings
   2. Cancer
   3. Inflammation
   4. Cardiovascular diseases
   5. 移植拒绝
   6. Respiratory
   7. Infectious diseases
7. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Technology Platforms
   1. Key Findings
   2. Transgenic-Mouse
   3. Antibody Drug Conjugate
   4. Phage-Display
8. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Target Mechanism of Action
   1. Key Findings
   2. CGRP
   3. HER2.
   4. CTLA4
   5. TNF alpha
   6. EGFR
   7. VEGF.
   8. Anti CD
   9. 抗IL.
   10. IgGs, PD-1/PD-L1
9. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Care Delivery Setting
   1. Key Findings
   2. Primary
   3. Specialty Care
10. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Route of Administration
    1. Key Findings
    2. Subcutaneous
    3. Intravenous
11. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Drug Types
    1. Key Findings
    2. 品牌的生物制剂
    3. Biosimilars
12. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Region
    1. Key Findings
    2. North America
       1. U.S.
       2. Canada
    3. Europe
       1. UK
       2. Germany
       3. Rest of Europe
    4. Asia-Pacific
       1. China
       2. Japan
       3. India
       4. Rest of Asia-Pacific
    5. Latin America
       1. Brazil
       2. 墨西哥
    6. Middle East & Africa
       1. South Africa
       2. Rest of Middle East & Africa
13. Company Profiles
    1. Pfizer，Inc。，
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    2. GlaxoSmithKline PLC
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    3. 诺华AG
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    4. Merck & Co., Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    5. Eli Lily & Co.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    6. AstraZeneca
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    7. Amgen, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    8. 雅培实验室
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    9. Thermo Fisher Scientific, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. 近期发展
    10. Bistro-Myers Squibb.
        1. Overview
        2. Financials
        3. Product Benchmarking
        4. 近期发展
    11. Mylan N.V.
        1. Overview
        2. Financials
        3. Product Benchmarking
        4. 近期发展
    12. Daiichi Sankyo Company, Ltd.
        1. Overview
        2. Financials
        3. Product Benchmarking
        4. 近期发展
    13. Bayer AG
        1. Overview
        2. Financials
        3. Product Benchmarking
        4. 近期发展
    14. Hoffmann-La Roche Ltd.
        1. Overview
        2. Financials
        3. Product Benchmarking
        4. 近期发展
    15. Novo Nordisk A/S
        1. Overview
        2. Financials
        3. Product Benchmarking
        4. 近期发展